about
Noncoding RNAs in gastric cancer: Research progress and prospectsProgress in systemic therapy of advanced hepatocellular carcinomaCirculating tumor DNA in hepatocellular carcinoma: trends and challengesCD317 Promotes the survival of cancer cells through apoptosis-inducing factorGenetic Variants in the p14ARF/MDM2/TP53 Pathway Are Associated with the Prognosis of Esophageal Squamous Cell Carcinoma Patients Treated with Radical Resection.The role of extracellular vesicles in mediating progression, metastasis and potential treatment of hepatocellular carcinomaThe Role of Interleukin-17 in Lung CancerDiscovery of Anticancer Agents of Diverse Natural OriginPrognostic value of RDW in cancers: a systematic review and meta-analysisNew Progress of Epigenetic Biomarkers in Urological CancerChinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus: 2016 editionAssociation between the APEX1 Asp148Glu polymorphism and prostate cancer, especially among Asians: a new evidence-based analysisThe Growth of SGC-7901 Tumor Xenografts Was Suppressed by Chinese Bayberry Anthocyanin Extract through Upregulating KLF6 Gene ExpressionExposure to organochlorine pesticides and non-Hodgkin lymphoma: a meta-analysis of observational studiesUpregulation of FAM83D promotes malignant phenotypes of lung adenocarcinoma by regulating cell cycleCase-control study of metabolic syndrome and ovarian cancer in Chinese populationGenetic variants in regulatory regions of microRNAs are associated with lung cancer riskGenetic variants at 9p21.3 are associated with risk of esophageal squamous cell carcinoma in a Chinese populationReliability analysis of the Chinese version of the Functional Assessment of Cancer Therapy - Leukemia (FACT-Leu) scale based on multivariate generalizability theory.ETS (E26 transformation-specific) up-regulation of the transcriptional co-activator TAZ promotes cell migration and metastasis in prostate cancer.Review of Factors Related to the Thyroid Cancer Epidemic.Role of TIM-3 in ovarian cancer.Chinese health care system and clinical epidemiology.Primary Antibiotic Resistance of Helicobacter pylori in China.Gut microbiota and colorectal cancer.Association between Tumor Vasculogenic Mimicry and the Poor Prognosis of Gastric Cancer in China: An Updated Systematic Review and Meta-Analysis.Descriptive epidemiology of breast cancer in China: incidence, mortality, survival and prevalence.Gastric cancer - clinical and epidemiological aspects.Patterns of cancer screening, incidence and treatment disparities in China: protocol for a population-based studyAn integrated double-filtration microfluidic device for isolation, enrichment and quantification of urinary extracellular vesicles for detection of bladder cancerIdentification of a Low-Frequency Missense Variant in E2F Transcription Factor 7 Associated with Colorectal Cancer Risk In A Chinese PopulationExosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis.Comparison of prognostic nomograms based on different nodal staging systems in patients with resected gastric cancer.Clinical data from the real world: efficacy of Crizotinib in Chinese patients with advanced ALK-rearranged non-small cell lung cancer and brain metastasesFormononetin inhibits human bladder cancer cell proliferation and invasiveness via regulation of miR-21 and PTEN.The efficiency and safety of trastuzumab for advanced gastric and gastroesophageal cancer: a meta-analysis of five randomized controlled trials.The Efficacy of Brucea javanica Oil Emulsion Injection as Adjunctive Therapy for Advanced Non-Small-Cell Lung Cancer: A Meta-Analysis.Caspase 8 polymorphisms contribute to the prognosis of advanced lung adenocarcinoma patients after platinum-based chemotherapy.Efficacy and safety of everolimus in Chinese metastatic HR positive, HER2 negative breast cancer patients: a real-world retrospective study.Exploratory cohort study and meta-analysis of BIM deletion polymorphism in patients with epidermal growth factor receptor-mutant non-small-cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors
P2860
Q26740211-FB446CBE-718C-4382-90CF-F842972C1C18Q26740217-604208BD-DBF3-47A3-A943-F8B5FB0AF699Q26749417-C7947BD6-93BA-4A03-AB72-1140CE4E0964Q27468925-AF4D3401-B57F-4C4E-B463-DBE841F8FEE4Q27853395-6BB07605-9AC9-47DD-BF99-166D0D258DDCQ28066407-2315663E-3263-46DB-8D40-E21E8001E294Q28066949-11C941C3-E577-47FA-A232-48D3231A23DCQ28068341-5AD30C63-019A-4490-947A-3F6555B2A92AQ28069144-690E7722-4C48-4666-951C-64082EC9CB17Q28073982-0D5FA9CF-FBBE-4951-B160-E20407A6C0B0Q28077829-AF8C08A1-2BA0-4EFC-9A21-289EAFE38AC1Q28079902-6CD98890-9DF7-4F8F-9465-587284E9CAD4Q28392650-58A38AA1-CB42-490C-B9BB-8AE3A32B1D01Q28394380-FEEDBCDE-9D28-40E1-A487-FF31B47081E8Q28395073-C72B473A-D588-45E1-AA74-60152B2E4C17Q29248169-DF73EBD8-FD57-493F-AB00-ACF1A4787EEEQ29248375-75B417DD-9B1F-47CA-9421-654D9B18B562Q29248390-59292265-1DBF-44FB-ACE8-2D45E82878F6Q29994768-BFBBE47C-46D9-4FFA-881D-54A23D3F1963Q30008747-E547E378-552D-424F-B129-AA0706A76CDDQ30234328-8D73569E-3135-439E-B902-F15C2D036846Q30235023-DEDAEAF0-BCC7-4832-BCFD-D17BC1DE80C6Q30235035-B4634ED4-FEAA-4234-B48D-1656F83520B1Q30235219-B9D2FF63-7295-4799-BEA1-756B3609DF59Q30239806-30428B57-1B83-4291-B1B3-8A206254D53AQ30241815-3A2BA5C5-E7BB-4D62-BB36-A0D641836238Q30248287-ADC83934-62A7-4A58-B3A6-9794D219ECF2Q30248452-6C4564CA-EB03-4B3F-92D1-5F2BEEDB00E8Q30276194-760E03E3-353E-4EAC-BBFD-0F6E96102A11Q30358093-FD718C22-E23B-41A7-A99F-8D97E39A7113Q30399157-C972C4D4-C9B4-4DF9-9C60-04239BC685E9Q30845562-09917F51-C227-4258-974A-619EE20E547DQ30851464-421AB686-841D-4318-988F-31AAB3D3DA98Q31141961-CBBD8DCD-1050-4A36-99D0-E85C2600516FQ32182546-9F0151F5-4619-4723-B8E0-ADC08BE154CBQ33437413-09F14C6B-DFE7-487A-A916-D67DBD27E0FDQ33438129-488F61D6-9CA8-4908-9D6C-69DC3DE08B5CQ33439990-3B5E5BE6-E3F9-4D48-9E76-6533174CF146Q33441090-CE0FB3B9-7097-40E4-BB27-C7BE6A41B552Q33553528-54B0476E-490B-4C76-8409-46F3959252A5
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Cancer statistics in China, 2015.
@en
type
label
Cancer statistics in China, 2015.
@en
prefLabel
Cancer statistics in China, 2015.
@en
P2093
P356
P1433
P1476
Cancer statistics in China, 2015
@en
P2093
Ahmedin Jemal
Hongmei Zeng
Rongshou Zheng
Siwei Zhang
Wanqing Chen
Xue Qin Yu
P304
P356
10.3322/CAAC.21338
P407
P577
2016-01-25T00:00:00Z